1-5 of 5
Di Zhou
Close
Sort by
Journal Articles

Investigating the Drug Resistance Mechanisms of Refractory Diffuse Large B-Cell Lymphoma Based on Proteomic Research

Lintao Bi, Jianmin Ling, Di Zhou, Qibei Liu, Zhao Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6119.
https://doi.org/10.1182/blood-2023-185479
Published: 2023
Journal Articles

Non-Interventional Observational Analysis of the Clinical Outcomes with IO-FIVE (Immune-Oncology Fast In Vivo Efficacy Test) in Lymphoma Patients

Chanjuan Jin, Bin Xie, Di Zhou, Yanan Zhao, Wei Hua, Zhenle Bi, Yang Liu, Kaimeng Hu, Lintao Bi, Danyi Wen
Journal: Blood
Blood (2023) 142 (Supplement 1): 6130.
https://doi.org/10.1182/blood-2023-181478
Published: 2023
Journal Articles

A Novel Patient-Derived Xenograft Model IO-FIVE for Drug Discovery and Precision Medicine in Lymphoma and Leukemia Patients

Bin Xie, Chanjuan Jin, Yang Liu, Wei Hua, Zhenle Bi, Kaimeng Hu, Di Zhou, Yanan Zhao, Lintao Bi, Danyi Wen
Journal: Blood
Blood (2023) 142 (Supplement 1): 6121.
https://doi.org/10.1182/blood-2023-178997
Published: 2023
Journal Articles

Transfer Learning for Identifying Morphological Heterogeneity of Neutrophils Nuclei in Hematological Diseases Based on Nuclei Semantic Segmentations of Bone Marrow Smear

Hui Shao, Wen Gao, MD, Qi Zhang, Jun Li, Di Zhou, Lintao Bi, Yuansong BAI, PhD, Zhangzhen Shi
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-143460
Published: 2020
Journal Articles

MiR-181a Down-Regulates PARP1 By Enhancing Its Acetylation in MLL -Rearranged AML

Di Zhou, PhD, Jian Ouyang, MD, Bing Chen, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1388.
https://doi.org/10.1182/blood.V130.Suppl_1.1388.1388
Published: 2017